Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

Recruiting Observational Study
Syncope Pacemaker Asystole Neurally Mediated Syncope
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
64 (estimated)
Sponsor
Azienda Ospedaliera di Bolzano · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021 * Written informed consent Exclusion Criteria: * Other condition which explains syncope cause other than reflex syncope * Structural heart disease (valvular, ischaemic, cardiomyopathies)…
Contacts

Matthias Unterhuber, Dr. Dr.

0471 43 9950

matthias.unterhuber@gmail.com

CONTACT

Marco Tomaino, Dr.

0471 43 9950

marco.tomaino@sabes.it

CONTACT